Immune checkpoint inhibition with single fraction stereotactic radiosurgery does not increase risk of radiation necrosis medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Vitaly Margulis, MD, discusses key disease characteristics and patient factors to consider when selecting between IO/IO vs IO/TKI treatment combinations for the management of patients with renal cell carcinoma.
The trial evaluated whether adding radiation (SBRT) to immunotherapy (ICIs) could improve outcomes in a cohort with a variety of advanced solid tumors.
/PRNewswire/ American Skin Association has announced the names of the four Research Scholar Awards. Clinton Enos, MD of Eastern Virginia Medical School has.